RNS Number : 3934B
Medgenics Inc
26 October 2009
Medgenics, Inc.
('Medgenics' or the 'Company')
26 October 2009
The Board of Medgenics announces that on 23 October 2009 Lord Leonard Steinberg (a Director of the Company) informed the Company that on 23 October 2009 he acquired in the market 25,000 common shares of US$ 0.0001 each ("Common Shares") in the Company at a price of 12 pence per Common Share.
Lord Steinberg's holding of Common Shares following this purchase is 18,609,725 Common Shares representing 15.7 % of the issued share capital (excluding his interest in warrants and convertible debentures as previously announced).
For further information, contact:
|
Medgenics, Inc.
Dr. Andrew L. Pearlman
|
Phone: +972 4 902 8900
|
|
Grayling (Financial PR, UK)
Jonathan Shillington
Alistair Scott
|
Phone: +44 7900 053 536
jonathan.shillington@uk.grayling.com
|
|
Blomfield Corporate Finance Limited (Nominated Adviser)
James Pinner
Alan MacKenzie
|
Phone: +44 207 444 0800
|
|
SVS Securities plc (Broker)
Ian Callaway
|
Phone: +44 207 638 5600
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEASEKASLNFFE